We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

GlaxoSmithKline is understood to be the sole bidder for Pfizer’s $15-20bn consumer health unit after Reckitt Benckiser pulled out. Reckitt’s shares jumped after it published a short statement ...

GSK plc (NYSE:GSK) tops our list for being one of the most undervalued stocks. The company was formerly known as GlaxoSmithKline and is a multinational biopharmaceutical and healthcare company ...

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

Me is potentially selling more than just your genetic data—the personal survey info it collected is just as much a privacy ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

The $16 billion dollar 'asset swap' deal between GlaxoSmithKline (GSK) and Novartis has been formally completed today, with the UK-headquartered company exchanging its oncology portfolio for the ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.